Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daniel Taussky & Guila Delouya. (2020) Impact of diabetes and metformin use on prostate cancer. Scandinavian Journal of Urology 54:6, pages 508-509.
Read now
Read now
Articles from other publishers (33)
James Yarmolinsky, Emmanouil Bouras, Andrei Constantinescu, Kimberley Burrows, Caroline J. Bull, Emma E. Vincent, Richard M. Martin, Olympia Dimopoulou, Sarah J. Lewis, Victor Moreno, Marijana Vujkovic, Kyong-Mi Chang, Benjamin F. Voight, Philip S. Tsao, Marc J. Gunter, Jochen Hampe, Andrew J. Pellatt, Paul D. P. Pharoah, Robert E. Schoen, Steven Gallinger, Mark A. Jenkins, Rish K. Pai, Rosalind A. Eeles, Christopher A. Haiman, Zsofia Kote-Jarai, Fredrick R. Schumacher, Sara Benlloch, Ali Amin Al Olama, Kenneth Muir, Sonja I. Berndt, David V. Conti, Fredrik Wiklund, Stephen Chanock, Ying Wang, Victoria L. Stevens, Catherine M. Tangen, Jyotsna Batra, Judith A. Clements, Henrik Grönberg, Nora Pashayan, Johanna Schleutker, Demetrius Albanes, Stephanie Weinstein, Alicja Wolk, Catharine M. L. West, Lorelei A. Mucci, Géraldine Cancel-Tassin, Stella Koutros, Karina Dalsgaard Sørensen, Eli Marie Grindedal, David E. Neal, Freddie C. Hamdy, Jenny L. Donovan, Ruth C. Travis, Robert J. Hamilton, Sue Ann Ingles, Barry S. Rosenstein, Yong-Jie Lu, Graham G. Giles, Adam S. Kibel, Ana Vega, Manolis Kogevinas, Kathryn L. Penney, Jong Y. Park, Janet L. Stanford, Cezary Cybulski, Børge G. Nordestgaard, Sune F. Nielsen, Hermann Brenner, Christiane Maier, Jeri Kim, Esther M. John, Manuel R. Teixeira, Susan L. Neuhausen, Kim De Ruyck, Azad Razack, Lisa F. Newcomb, Davor Lessel, Radka Kaneva, Nawaid Usmani, Frank Claessens, Paul A. Townsend, Jose Esteban Castelao, Monique J. Roobol, Florence Menegaux, Kay-Tee Khaw, Lisa Cannon-Albright, Hardev Pandha, Stephen N. Thibodeau, David J. Hunter, Peter Kraft, William J. Blot, Elio Riboli, Dipender Gill & Kostas K. Tsilidis. (2023) Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis. Diabetologia 66:8, pages 1481-1500.
Crossref
Crossref
Tahlia Scheinberg, Blossom Mak, Lisa Butler, Luke Selth & Lisa G. Horvath. (2023) Targeting lipid metabolism in metastatic prostate cancer. Therapeutic Advances in Medical Oncology 15, pages 175883592311528.
Crossref
Crossref
Muyue Yang, Jipeng Li, Zeyang Liu, Haiyang Zhang, Jin Liu, Yan Liu, Ai Zhuang, Huifang Zhou, Ping Gu & Xianqun Fan. (2022) An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy. Biomaterials Science 10:24, pages 7077-7092.
Crossref
Crossref
Visalini Nair-Shalliker, Albert Bang, Sam Egger, Xue Qin Yu, Karen Chiam, Julia Steinberg, Manish I. Patel, Emily Banks, Dianne L. O’Connell, Bruce K. Armstrong & David P. Smith. (2022) Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study. British Journal of Cancer 127:4, pages 735-746.
Crossref
Crossref
Vincenzo Sorrenti, Francesca Benedetti, Alessandro Buriani, Stefano Fortinguerra, Giada Caudullo, Sergio Davinelli, Davide Zella & Giovanni Scapagnini. (2022) Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks. Pharmaceuticals 15:8, pages 912.
Crossref
Crossref
José Manuel Sánchez-Maldonado, Ricardo Collado, Antonio José Cabrera-Serrano, Rob Ter Horst, Fernando Gálvez-Montosa, Inmaculada Robles-Fernández, Verónica Arenas-Rodríguez, Blanca Cano-Gutiérrez, Olivier Bakker, María Inmaculada Bravo-Fernández, Francisco José García-Verdejo, José Antonio López López, Jesús Olivares-Ruiz, Miguel Ángel López-Nevot, Laura Fernández-Puerta, José Manuel Cózar-Olmo, Yang Li, Mihai G. Netea, Manuel Jurado, Jose Antonio Lorente, Pedro Sánchez-Rovira, María Jesús Álvarez-Cubero & Juan Sainz. (2022) Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis. Cancers 14:10, pages 2376.
Crossref
Crossref
Brooks P. LeitnerStephan SiebelNgozi D. AkingbesoteXinyi ZhangRachel J. Perry. (2022) Insulin and cancer: a tangled web. Biochemical Journal 479:5, pages 583-607.
Crossref
Crossref
Roni M. Joentausta, Antti Rannikko & Teemu J. Murtola. (2021) Prostate Cancer–specific Survival After Radical Prostatectomy Is Improved Among Metformin Users but Not Among Other Antidiabetic Drug Users. European Urology Open Science 34, pages 86-93.
Crossref
Crossref
Giorgio Gandaglia, Riccardo Leni, Freddie Bray, Neil Fleshner, Stephen J. Freedland, Adam Kibel, Pär Stattin, Hendrick Van Poppel & Carlo La Vecchia. (2021) Epidemiology and Prevention of Prostate Cancer. European Urology Oncology 4:6, pages 877-892.
Crossref
Crossref
Antonio J. León-González, Juan M. Jiménez-Vacas, Antonio C. Fuentes-Fayos, Andre Sarmento-Cabral, Aura D. Herrera-Martínez, Manuel D. Gahete & Raúl M. Luque. (2021) Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers. Current Opinion in Pharmacology 60, pages 17-26.
Crossref
Crossref
Max Enwald, Terho Lehtimäki, Pashupati P. Mishra, Nina Mononen, Teemu J. Murtola & Emma Raitoharju. (2021) Human Prostate Tissue MicroRNAs and Their Predicted Target Pathways Linked to Prostate Cancer Risk Factors. Cancers 13:14, pages 3537.
Crossref
Crossref
Ville J. Vihervuori, Kirsi Talala, Kimmo Taari, Jorma Lahtela, Teuvo L.J. Tammela, Anssi Auvinen, Paavo Raittinen & Teemu J. Murtola. (2021) Antidiabetic Drugs and Prostate Cancer Prognosis in a Finnish Population-Based Cohort. Cancer Epidemiology, Biomarkers & Prevention 30:5, pages 982-989.
Crossref
Crossref
Miłosz Knura, Wojciech Garczorz, Adam Borek, Franciszek Drzymała, Krystian Rachwał, Kurian George & Tomasz Francuz. (2021) The Influence of Anti-Diabetic Drugs on Prostate Cancer. Cancers 13:8, pages 1827.
Crossref
Crossref
A. Vettenranta, T. J. Murtola, K. Talala, K. Taari, U.-H. Stenman, T. L. J. Tammela & A. Auvinen. (2021) Outcomes of prostate cancer screening among men using antidiabetic medication. Scientific Reports 11:1.
Crossref
Crossref
Shifteh Abedian, Ali Abbasi, Anthonius de Boer, Bruno H. Stricker, Stephan J. L. Bakker, Pim van der Harst, Sanaz Sedaghat, Maryam Darvishian, M. Arfan Ikram, Gerjan Navis, Abbas Dehghan, Ido Pen, Ronald P. Stolk, Harold Snieder, Olaf H. Klungel, Patrick Souverein & Behrooz Z. Alizadeh. (2021) Effect of metabolic genetic variants on long-term disease comorbidity in patients with type 2 diabetes. Scientific Reports 11:1.
Crossref
Crossref
Kui Zhang, Peng Bai, Hao Dai & Zhenhua Deng. (2021) Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Primary Care Diabetes 15:1, pages 52-58.
Crossref
Crossref
Moumita Nath, Sayantan Nath & Yashmin Choudhury. (2021) The impact of thiazolidinediones on the risk for prostate cancer in patients with type 2 diabetes mellitus: A review and meta-analysis. Meta Gene 27, pages 100840.
Crossref
Crossref
Francesca Benedetti, Vincenzo Sorrenti, Alessandro Buriani, Stefano Fortinguerra, Giovanni Scapagnini & Davide Zella. (2020) Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways. Viruses 12:12, pages 1458.
Crossref
Crossref
E. Lin, Hans Garmo, Mieke Van Hemelrijck, Jan Adolfsson, Pär Stattin, Björn Zethelius & Danielle Crawley. (2020) Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study. BMC Cancer 20:1.
Crossref
Crossref
Mette Nørgaard, Bianka Darvalics & Reimar Wernich Thomsen. (2020) Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study. BMJ Open 10:12, pages e041875.
Crossref
Crossref
Hyun Kyu Ahn, Young Hwa Lee & Kyo Chul Koo. (2020) Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review. International Journal of Molecular Sciences 21:22, pages 8540.
Crossref
Crossref
Norah Saeed Al-ZahraniDr.Dr., Ehab M. M. AliDr.Dr., Abdulaziz A. KalantanDr.Dr. & Mazin Abdulaziz ZamzamiDr.Dr.. (2020) An update on the effectiveness of metformin alone and with chemotherapy drugs on tumor cells. European Journal of Cell Science 2:1, pages 10-19.
Crossref
Crossref
Riccardo Campi, Sabine D. Brookman-May, Jose Daniel Subiela Henríquez, Bülent Akdoğan, Maurizio Brausi, Tobias Klatte, Johan F. Langenhuijsen, Estefania Linares-Espinos, Martin Marszalek, Morgan Roupret, Christian G. Stief, Alessandro Volpe, Andrea Minervini & Oscar Rodriguez-Faba. (2019) Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology. European Urology Focus 5:6, pages 1029-1057.
Crossref
Crossref
Teemu J. Murtola, Samueli M. Sälli, Kirsi Talala, Kimmo Taari, Teuvo L. J. Tammela & Anssi Auvinen. (2019) Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer. Prostate Cancer and Prostatic Diseases 22:3, pages 453-460.
Crossref
Crossref
Simona Di Francesco, Iole Robuffo, Marika Caruso, Giulia Giambuzzi, Deborah Ferri, Andrea Militello & Elena Toniato. (2019) Metabolic Alterations, Aggressive Hormone-Naïve Prostate Cancer and Cardiovascular Disease: A Complex Relationship. Medicina 55:3, pages 62.
Crossref
Crossref
Zhaohan Feng, Xiaofeng Zhou, Naibo Liu, Jianfeng Wang, Xing Chen & Xin Xu. (2019) Metformin use and prostate cancer risk. Medicine 98:12, pages e14955.
Crossref
Crossref
Kancheng He, Huating Hu, Senlin Ye, Haohui Wang, Rongrong Cui & Lu Yi. (2019) The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis. Scientific Reports 9:1.
Crossref
Crossref
Christine Degasper, Andrea Brunner, Natalie Sampson, Irina Tsibulak, Verena Wieser, Hannah Welponer, Christian Marth, Heidi Fiegl & Alain Gustave Zeimet. (2019) NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer. Tumor Biology 41:2, pages 101042831983000.
Crossref
Crossref
Ritwika Mallik & Tahseen A. Chowdhury. (2018) Metformin in cancer. Diabetes Research and Clinical Practice 143, pages 409-419.
Crossref
Crossref
Teemu J. Murtola, Ville JY Vihervuori, Jorma Lahtela, Kirsi Talala, Kimmo Taari, Teuvo LJ Tammela & Anssi Auvinen. (2018) Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. British Journal of Cancer 118:9, pages 1248-1254.
Crossref
Crossref
Jeannette M. Schenk & Jonathan L. Wright. 2018. Energy Balance and Prostate Cancer. Energy Balance and Prostate Cancer
43
70
.
Jee Soo Park, Kwang Suk Lee, Won Sik Ham, Byung Ha Chung & Kyo Chul Koo. (2017) Impact of metformin on serum prostate-specific antigen levels. Medicine 96:51, pages e9427.
Crossref
Crossref
Pascal Weber. (2017) Antidiabetika und Prostatakarzinomrisiko. Praxis 106:18, pages 1011-1012.
Crossref
Crossref